Product Images Venlafaxine Hydrochloride

This text describes the drugs that interact with CYP2D6 and CYP206 PMs such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Imipramine, and Lithium. It also provides recommendations for PK fold change and 90% Cl for each drug concerning factors like Cmax and blood pressure. The text also includes values for Change relative to the reference value, but it is not clear what it is referring to.*

This appears to be a list of various drugs and their analyte PKfold change and 90% C recommendation. However, the text is incomplete and contains errors, making it difficult to fully understand and provide a useful description.*

This appears to be a table showing recommendations for dosage adjustments for different analytes in patients with various conditions such as hepatic or renal impairment, age, gender, and CYP206 polymorphism. The fold change and 90% CI values are also provided. It is likely a resource for healthcare professionals to assist in determining appropriate dosages for their patients.*

This is a medication description for Venlafaxine Hydrochloride Extended-Release Capsules, USP. The capsules contain 37.5 mg of Venlafaxine Hydrochloride. The medication should be stored between 20° to 25° C (68° to 77° F) or in excursions permitted to 15° to 30° C (59° to 86° F). This package is child-resistant and should be dispensed in a tight, light-resistant container with child-resistant closure. There are 30 capsules in the package and the medication is available by prescription only. The medication guide for this product is available online. The medication is repackaged by Bryant Ranch Prepack and manufactured by Yichang Humanwell Oral Solid Dosage Plant.*